# BioNexus Gene Lab Corp: Form 8-K/A, filed Mar 11, 2021

- Company: [BioNexus Gene Lab Corp](/companies/bglc.md) (CIK 1737523)
- Form: 8-K/A
- Filed: 2021-03-11
- Accepted by EDGAR: Mar 11, 2021, 20:54 ET
- Period: 2020-12-31
- Accession: 0001477932-21-001370
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737523/000147793221001370/bion_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737523/000147793221001370/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737523/000147793221001370/bion_8ka.htm

Filed Mar 11, 2021.
Source: SEC EDGAR, the filing index for accession 0001477932-21-001370. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
